Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
South Danish Diabetes Study (SDDS)
NCT00121966Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2003
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Hemoglobin A1c at 2 years. Started Jan 2003; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00121966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121966.